Arrowhead Pharmaceuticals, Inc. (0HI3.L) LSE

64.86

+0.2488(+0.39%)

Updated at December 04 07:02PM

Currency In USD

Valuation

Market Cap4.61B
Enterprise Value4.64B
P/E Ratio-60.57
PEG Ratio-7.02
Price/Sales Ratio14.99
Price/Book Ratio17.3
Enterprise/Revenue15.96
Enterprise/EBITDA-181.38

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.18

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.41

Income Statement

Revenue829.45M
Revenue/Share4.29
Gross Profit0
EBITDA98.35M
Net Income-1.63M
Diluted EPS-0.01

Balance Sheet

Total Cash900.37M
Total Cash/Share6.48
Total Debt713.29M
Total Debt/Equity1.37
Current Ratio4.87
Book Value Per Share3.74

Price History

52-Week Change186.86
52-Week High67.13
52-Week Low20.75
Moving Average 50 Days32.83
Moving Average 200 Days31.06

Statistics

Average Volume1,779
Shares Outstanding135.8M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A